Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 143.2 SEK 0.14%
Market Cap: 11.5B SEK

Wall Street
Price Targets

BIOT Price Targets Summary
Biotage AB

There are no price targets for BIOT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biotage AB Competitors:
Price Targets
2268
WuXi XDC Cayman Inc
22% Upside
STVN
Stevanato Group SpA
41% Upside
AZTA
Azenta Inc
15% Upside
ONESOURCE
Onesource Specialty Pharma Ltd
48% Upside
WST
West Pharmaceutical Services Inc
29% Upside
OABI
OmniAb Inc
292% Upside
GENO
Genovis AB
70% Upside
TEM
Tempus AI Inc
46% Upside

Revenue
Forecast

Revenue Estimate
Biotage AB

For the last 13 years the compound annual growth rate for Biotage AB's revenue is 13%. The projected CAGR for the next 3 years is 7%.

13%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biotage AB

For the last 13 years the compound annual growth rate for Biotage AB's operating income is 23%. The projected CAGR for the next 3 years is 16%.

23%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotage AB

For the last 13 years the compound annual growth rate for Biotage AB's net income is 18%. The projected CAGR for the next 3 years is 17%.

18%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOT's stock price target?
Not Available

BIOT doesn't have any price targets made by Wall Street professionals.

What is Biotage AB's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Biotage AB's revenue is 13%. The projected CAGR for the next 3 years is 7%.

What is Biotage AB's Operating Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Biotage AB's operating income is 23%. The projected CAGR for the next 3 years is 16%.

What is Biotage AB's Net Income forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Biotage AB's net income is 18%. The projected CAGR for the next 3 years is 17%.

Back to Top